TG Therapeutics, Inc. (TGTX)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
As of 03:07PM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 2.54B |
| Enterprise Value | 2.43B |
| Trailing P/E | 182.44 |
| Forward P/E | 163.93 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 10.44 |
| Price/Book (mrq) | 15.81 |
| Enterprise Value/Revenue | 10.40 |
| Enterprise Value/EBITDA | 93.14 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 2.32 |
| 52-Week Change 3 | -52.11% |
| S&P500 52-Week Change 3 | 22.43% |
| 52 Week High 3 | 35.32 |
| 52 Week Low 3 | 6.46 |
| 50-Day Moving Average 3 | 15.15 |
| 200-Day Moving Average 3 | 13.35 |
Share Statistics
| Avg Vol (3 month) 3 | 3.81M |
| Avg Vol (10 day) 3 | 5.38M |
| Shares Outstanding 5 | 154.54M |
| Implied Shares Outstanding 6 | 154.54M |
| Float 8 | 134.89M |
| % Held by Insiders 1 | 9.55% |
| % Held by Institutions 1 | 59.04% |
| Shares Short (Apr 15, 2024) 4 | 35.71M |
| Short Ratio (Apr 15, 2024) 4 | 14.61 |
| Short % of Float (Apr 15, 2024) 4 | 28.35% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 23.13% |
| Shares Short (prior month Mar 15, 2024) 4 | 34.19M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 100:5625 |
| Last Split Date 3 | Apr 30, 2012 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Mar 31, 2024 |
Profitability
| Profit Margin | 14.24% |
| Operating Margin (ttm) | -14.60% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 289.33M |
| Revenue Per Share (ttm) | 2.02 |
| Quarterly Revenue Growth (yoy) | 713.50% |
| Gross Profit (ttm) | N/A |
| EBITDA | 48.55M |
| Net Income Avi to Common (ttm) | 41.2M |
| Diluted EPS (ttm) | 0.09 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 217.51M |
| Total Cash Per Share (mrq) | 1.5 |
| Total Debt (mrq) | 111.15M |
| Total Debt/Equity (mrq) | 69.25% |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 1.13 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
© 2024 Yahoo. All rights reserved.